ELDRED KARY
SEC insider (Form 3/4/5 filer). CIK 0001543425. Director at GALECTIN THERAPEUTICS INC (GALT). 7 reported Form 4/5 transactions since Sep 2024; latest on Feb 6, 2026. Located in NORCROSS, GA.
Companies ELDRED KARY has filed insider reports for
- GALECTIN THERAPEUTICS INC (GALT): Director
ELDRED KARY
CIK: 0001543425
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GALECTIN THERAPEUTICS INC
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Feb 6, 2026GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect300 shares at avg. $2.70$810 - Jan 16, 2026GALT
GALECTIN THERAPEUTICS INC
AwardDirectStock option (right to buy)
60K shares- - Dec 23, 2025GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect700 shares at avg. $3.73$3K - Jul 21, 2025GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect1K shares at avg. $2.92$3K - Jan 23, 2025GALT
GALECTIN THERAPEUTICS INC
AwardDirectStock Option (right to buy)
60K shares- - Dec 24, 2024GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect13.5K shares at avg. $0.82$11K - Oct 23, 2024GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect500 shares at avg. $2.60$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 6, 2026 | GALT GALECTIN THERAPEUTICS INC | Purchase | 300 | $2.70 | $810 | Direct |
| Jan 16, 2026 | GALT GALECTIN THERAPEUTICS INC | Award Stock option (right to buy) | 60,000 | - | - | Direct |
| Dec 23, 2025 | GALT GALECTIN THERAPEUTICS INC | Purchase | 700 | $3.73 | $2,611 | Direct |
| Jul 21, 2025 | GALT GALECTIN THERAPEUTICS INC | Purchase | 1,000 | $2.92 | $2,925 | Direct |
| Jan 23, 2025 | GALT GALECTIN THERAPEUTICS INC | Award Stock Option (right to buy) | 60,000 | - | - | Direct |
| Dec 24, 2024 | GALT GALECTIN THERAPEUTICS INC | Purchase | 13,469 | $0.82 | $11,045 | Direct |
| Oct 23, 2024 | GALT GALECTIN THERAPEUTICS INC | Purchase | 500 | $2.60 | $1,300 | Direct |
1-7 of 7 transactions